Quick Answer
IMPACT BIOMEDICAL INC. reported Revenue (ASC 606) of $32.0 thousand for fiscal year 2025.
IMPACT BIOMEDICAL INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $32.0K | -36.0% |
| 2022 | $50.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.0K | — | +157.1% |
| June 30, 2025 | $7.0K | — | -86.0% |
| June 30, 2022 | $50.0K | — | — |
- IMPACT BIOMEDICAL INC. showed a decrease of -36.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2022–2025 period, IMPACT BIOMEDICAL INC.’s revenue (asc 606) has declined by 36.0% (from $50.0 thousand to $32.0 thousand).
- The most recent figure is from IMPACT BIOMEDICAL INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: